{"id":17372,"date":"2022-08-31T12:30:55","date_gmt":"2022-08-31T12:30:55","guid":{"rendered":"https:\/\/clinlabint.com\/?p=17372"},"modified":"2022-09-02T07:59:19","modified_gmt":"2022-09-02T07:59:19","slug":"olympus-provi-cm20-wins-highest-honour-in-red-dot-design-award","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/olympus-provi-cm20-wins-highest-honour-in-red-dot-design-award\/","title":{"rendered":"Olympus Provi CM20 wins highest honour in Red Dot Design Award"},"content":{"rendered":"
\n

\r\n\"Bio-Rad<\/a>\r\n<\/p>\n<\/div><\/section><\/div>

<\/p>\n<\/div><\/section>
\n

Olympus Provi CM20 wins highest honour in Red Dot Design Award<\/h1>\/ in E-News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\n

The Olympus Provi CM20 incubation monitoring system has won the prestigious “Best of the Best” award in the Product Design category of the 2022 Red Dot Design Award. This Award is bestowed on a product that the Red Dot Jury deems as groundbreaking and is the highest honour given in this world-renowned design competition.<\/h3>\n

<\/p>\n

Olympus Provi CM20 is a product of Evident, a wholly owned subsidiary of Olympus. The CM20 incubation monitoring system automatically measures the number and density of cells in a cell culture and enables users to monitor cells remotely while the culture vessel is in an incubator that maintains an endogenous-like environment. Cell culture operations, which were traditionally dependent on the user’s experience, technology and skill have been streamlined through the CM20 system’s monitoring and quantification features, helping improve researcher\u2019s work efficiency and experiment consistency.<\/p>\n<\/div><\/section>
\n

\"\"<\/div><\/div><\/div>
\n